These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31239156)

  • 41. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients.
    Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM
    Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.
    Rich JT; Milov S; Lewis JS; Thorstad WL; Adkins DR; Haughey BH
    Laryngoscope; 2009 Sep; 119(9):1709-19. PubMed ID: 19572271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of the Eighth Edition American Joint Committee on Cancer Staging System for HPV-Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
    Badhey AK; Olson A; Kadakia S; Russo J; Ting P; Khalid M; Yao M; Teng MS; Genden EM; Miles BA; Chai RL
    Laryngoscope; 2018 May; 128(5):1133-1139. PubMed ID: 28990700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
    Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
    Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPV/p16-positive oropharyngeal cancer treated with transoral robotic surgery: The roles of margins, extra-nodal extension and adjuvant treatment.
    Nichols DS; Zhao J; Boyce BJ; Amdur R; Mendenhall WM; Danan D; Hitchcock K; Ning K; Keyes K; Lee JH; Dziegielewski PT
    Am J Otolaryngol; 2021; 42(1):102793. PubMed ID: 33130532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre.
    Lörincz BB; Möckelmann N; Busch CJ; Münscher A; Sehner S; Dalchow CV; Knecht R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1028-33. PubMed ID: 25968617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
    Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis.
    Park DA; Lee MJ; Kim SH; Lee SH
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):644-649. PubMed ID: 31627931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transoral robotic surgery for oropharyngeal and tongue cancer in the United States.
    Chung TK; Rosenthal EL; Magnuson JS; Carroll WR
    Laryngoscope; 2015 Jan; 125(1):140-5. PubMed ID: 25093603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of human papillomavirus and smoking on survival outcomes after transoral robotic surgery.
    Stucken CL; de Almeida JR; Sikora AG; Tong CC; Genden EM
    Head Neck; 2016 Mar; 38(3):380-6. PubMed ID: 25351893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early adoption of transoral robotic surgical program: preliminary outcomes.
    Cognetti DM; Luginbuhl AJ; Nguyen AL; Curry JM
    Otolaryngol Head Neck Surg; 2012 Sep; 147(3):482-8. PubMed ID: 22496060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
    Yver CM; Shimunov D; Weinstein GS; Rajasekaran K; Cannady SB; Lukens JN; Lin A; Swisher-McClure S; Cohen RB; Aggarwal C; Bauml JM; Loevner LA; Newman JG; Chalian AA; Rassekh CH; Basu D; O'Malley BW; Brody RM
    Oral Oncol; 2021 Jul; 118():105307. PubMed ID: 33932874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Dharmalingam Jothinathan MK
    Oral Oncol; 2024 May; 152():106811. PubMed ID: 38636137
    [No Abstract]   [Full Text] [Related]  

  • 60. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study.
    Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR
    ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.